共 46 条
- [1] Davi G., Patrono C., Platelet activation and athero-thrombosis, N Engl J Med, 357, 24, pp. 2482-2494, (2007)
- [2] Statistics-health and Diseases: Myocardial Infarctions in Sweden 1987-2005, (2008)
- [3] Truelsen T., Piechowski-Jozwiak B., Bonita R., Et al., Stroke incidence and prevalence in Europe: A review of available data, Eur J Neurol, 13, 6, pp. 581-598, (2006)
- [4] Tran H., Anand S., Oral antiplatelet therapy in cerebrovas-cular disease, coronary artery disease and peripheral arterial disease, JAMA, 292, pp. 1867-1874, (2004)
- [5] A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE), Lancet, 348, 9038, pp. 1329-1339, (1996)
- [6] Hirsh J., Bhatt D., Comparitive benefits of clopidogrel and aspirin in high-risk patient populations: Lessons from the CAPRIE and CURE studies, Arch Intern Med, 164, pp. 2106-2110, (2004)
- [7] Ringleb P.A., Bhatt D.L., Hirsch A.T., Et al., Clopidogrel Versus Aspirin in Patients at Risk of Ischemic Events investigators Benefit of clopidogrel over aspirin is amplified in patients with a history of ischemic events, Stroke, 35, 2, pp. 528-532, (2004)
- [8] Carita P., Bego G., High-risk CAPRIE Patients and CAPRIE-like CHARISMA Patients: Analysis on Yearly Event Rates, (2006)
- [9] Heeg B.M., Damen J., Van Hout B.A., Oral antiplatelet therapy in secondary prevention of cardiovascular events: An assessment from the payer's perspective, Pharmacoeconom-ics, 25, 12, pp. 1063-1082, (2007)
- [10] Treatment and Prevention of Coronary Heart Disease by Lowering Plasma Cholesterol Levels., (1998)